FindTrial
Sign In

Docosahexaenoic Acid on Breath Holding Spells in Children

Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03965988
Enrollment
60
Registered
2019-05-29
Start date
2018-05-01
Completion date
2028-12-31
Last updated
2019-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breath Holding Attack

Brief summary

DHA on Breath Holding Spells

Detailed description

Effect of DHA on Breath Holding Spells

Interventions

DRUGDHA

Docosahexaenoic acid

DRUGPlacebo

Placebo

Sponsors

Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Children with newly diagnosed sprlls

Exclusion criteria

Other treatment as iron and piracetam

Design outcomes

Primary

MeasureTime frameDescription
Frequency of the spells6 monthsNumber of attacks

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, ass. prof.
sheriefabdelsalam@yahoo.com00201147773440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026